Almonty’s Sangdong Ramp-Up Hits the Tape as a Cleansing Notice and Technical Wobbles Complicate the Narrative
Published on 07/03/2026 at 13:25 | Redaktion boerse-global.de
The tungsten miner Almonty Industries is threading a needle. Its Sangdong mine in South Korea has just moved from construction into active ore processing, turning a stockpile valued at roughly $68 million into a potential revenue stream. Yet on the same week that milestone landed, the company filed a cleansing notice with the ASX for a modest issuance of 145,000 new ordinary shares — a procedural move that nonetheless underscores the governance scrutiny accompanying any capital event, no matter how small.
The notice, lodged on 2 July 2026, allows the secondary-market sale of the shares without a full prospectus, relying on an exemption under Section 708A of Australian corporate law. Almonty certified it had met all reporting obligations under Chapter 2M and that no undisclosed information existed regarding its assets, prospects, or the rights attached to the new shares. For a company transitioning from developer to producer, the transparency gesture is deliberate — but it lands as the market is already wrestling with much bigger questions about valuation.
A $68 Million Ore Pile Meets a Wide Fair-Value Spread
Sangdong’s processing facility has begun treating previously stockpiled ore, turning what was a development project into an active tungsten-concentrate producer. The quality of that feedstock, valued at around $68 million, will be the first real test of the operation’s economics. Ten fair-value estimates submitted via the Simply Wall St community capture the deep uncertainty: they span from C$0.67 to C$61.02 per share. No narrower range signals how unsettled investors are about pricing the shift from construction to cash generation.
The company’s recent financials provide some grounding. First-quarter 2026 revenue jumped 221% to $25.4 million, driven by the rising tungsten APT spot price and strong output from the Panasqueira mine in Portugal. Operating cash flow swung positive to $9.7 million from a negative $4.4 million in the year-ago period. As of 31 March, Almonty held $259.9 million in cash and a net working capital position of $169.5 million. Full-year 2025 revenue was $32.5 million, up 13% from $28.8 million, and rolling twelve-month revenue stood at $36.2 million in early June, according to PitchBook.
Should investors sell immediately? Or is it worth buying Almonty?
The Stock Market Loves the Story — Then Punches the Numbers
The equity has been on a blistering run. From a market cap of roughly $920 million on 15 July 2025, the stock touched $6.64 billion by 22 April 2026 — a 621% surge — before retreating. On 4 June, PitchBook reported a market cap of $5.87 billion; MacroTrends pegged it at $5.06 billion on 10 June. Inclusion in the Russell 1000 and Russell 3000 indices on 29 June 2026 was expected to boost liquidity, but the subsequent price action tells a different story.
At the close of trading on 2 July, the day of the cleansing notice, shares sat at C$22.33, down 2.91% for the week and nearly 20% on a monthly basis. The stock is now 33% below its 52-week high of C$33.35 set in April. Technically, the picture is deteriorating: the price has slipped below both the 50-day moving average (C$26.27) and the 100-day average (C$25.19), while the 200-day average at C$18.27 offers the nearest support — more than 22% below the current level. An RSI of 39.4 points to persistent selling pressure, and 30-day annualised volatility of nearly 90% underscores how nervy the tape has become.
Bulls Bet on the Ramp, Bears Watch the Cost Curve
Optimists argue that the Sangdong ramp-up is the definitive catalyst. If the plant runs reliably and converts that $68 million stockpile into revenue, operating losses should shrink rapidly. The Russell inclusion adds passive demand, and the Western push for non-Chinese tungsten supply for defence and advanced manufacturing creates a structural tailwind.
Almonty at a turning point? This analysis reveals what investors need to know now.
Skeptics counter that the share price has already discounted much of that success. The ramp-up itself carries execution risk — cost overruns, operational snags, and the perennial threat of further equity dilution. Even after the recent pullback, the company remains unprofitable on an earnings basis, and the gap between a still-modest revenue base and a multibillion-dollar market cap remains wide. The cleansing notice, though minor in size, reminds the market that any future capital needs could be met through additional issuances, potentially diluting existing holders.
Almonty has strengthened its management, relocated its headquarters, and now commands a place in leading indices. The next few weeks will determine whether Sangdong’s processing line can run at nameplate throughput and cost targets, or whether the technical and fundamental wobbles become more than just a passing correction.
Ad
Almonty Stock: New Analysis - 3 July
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
